[:no]Disputas | Luka Tandaric | 23.05.25[:en]Defence | Luka Tandaric | 23.05.25[:]

[:no]

DET MEDISINSKE FAKULTET

UNIVERSITETET I BERGEN 

DISPUTAS – PH.D.-GRADEN 

Luka Tandaric

Kandidaten utgår fra Klinisk institutt 2

Hovedveileder: professor Line Bjørge
Medveiledere: professor Emmet McCormack, ph.d. Liv Cecilie Vestrheim Thomsen og forsker Katrin Kleinmanns

Prøveforelesning: Fredag 23. mai 2025 kl. 10.15

Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28

Oppgitt emne: «Targeted therapies in cancer – from their introduction to future perspectives»

Dispuptas: Fredag 23. mai 2025 kl. 12.15

Sted: Auditorium, Armauer Hansens Hus, Haukelandsveien 28

Avhandlingens tittel: “Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade”

  1. opponent: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgia
  2. opponent: Professor Leticia Oliveira-Ferrer, Universitätsklinikum Hamburg-Eppendorf, Tyskland
  3. medlem av komiteen: Forsker Carina Strell, Universitetet i Bergen

Disputasen blir ledet av professor emerita Birgitta Åsjø.

Åpent for alle interesserte

[:en]

FACULTY OF MEDICINE
UNIVERSITY OF BERGEN

DEFENSE – PH.D. DEGREE

Luka Tandaric

The candidate is affiliated with the Department of Clinical Science (Klinisk institutt 2)
Main supervisor: Professor Line Bjørge
Co-supervisors: Professor Emmet McCormack, Ph.D. Liv Cecilie Vestrheim Thomsen, and Researcher Katrin Kleinmanns

Trial lecture:Friday, May 23, 2025, at 10:15 AM


Location: Auditorium, Armauer Hansen’s House, Haukelandsveien 28
Assigned topic«Targeted therapies in cancer – from their introduction to future perspectives»

Public defense:Friday, May 23, 2025, at 12:15 PM

Location: Auditorium, Armauer Hansen’s House, Haukelandsveien 28

Title of the dissertation:
«Rethinking High-Grade Serous Ovarian Carcinoma: Towards Personalized Immunotherapy through Preclinical, Translational and Clinical Evaluation of Combined CD73 and PD-L1 Blockade»

1st opponent: Professor Frederic Amant, Katholieke Universiteit Leuven, Belgium
2nd opponent: Professor Leticia Oliveira-Ferrer, University Medical Center Hamburg-Eppendorf, Germany
3rd member of the committee: Researcher Carina Strell, University of Bergen

The defense will be chaired by Professor Emerita Birgitta Åsjø.

Open to all interested parties

[:]

Legg igjen en kommentar

Din e-postadresse vil ikke bli publisert. Obligatoriske felt er merket med *